Answers are grounded in this paper and cite their sources.
Introduction: Ocular surface squamous neoplasia (OSSN) characterizes a spectrum of dysplastic and malignant epithelial lesions concerning the conjunctiva and cornea. The objective was to analyze the clinically diagnosed OSSN cases with the help of imaging studies and guide management decisions based on excisions with a 2-4 mm margin followed by scleral patch graft or amniotic membrane graft and topical chemotherapy with interferon Alfa-2b, mitomycin, or 5-fluorouracil (5FU) for the treatment modalities. Material and Methods: An observational study was conducted among 30 patients in a tertiary care center for a period of 30 months. Demographic and clinical features, as well as diagnostic features, especially anterior segment optical coherence tomography (ASOCT) and ultrasound biomicroscopy (UBM), and treatment features in patients presenting with OSSN were studied. Results: In the present study, the age group of about 46-60 years (46.7%) was more prevalent, with a mean age of 53.0 ± 12.6 years. The majority of participants were male. Regarding slit lamp examination, the majority of patients observed Leucoplakia. On ASOCT examination, thickening of the epithelium was observed in all the study participants, followed by epithelial hyper-reflectivity and abrupt transition. For UBM examination, a hyper-echoic tumor surface was observed, followed by hypoechoic stroma among study participants. Conclusion: The management of OSSN has shifted from primarily surgical treatments to personalized multimodal therapy due to breakthroughs in diagnostic imaging and topical chemotherapy. To prevent recurrence and save eyesight, early diagnosis and continuing follow-up are still important.
No takes yet. Share an insight, caveat, or question.
Dave et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: